how bad is semaglutide Off-brand Ozempic and Wegovy weight-loss drugs are a idea, FDA says GLP-1s 101: What the science

Semaglutide slows digestion, which can sometimes lead to gastrointestinal issues like diarrhea or vomiting

Weight loss was significant in outcome trials, ranging from a 0.6 kg reduction at 12 weeks in the ELIXA trial to a 4.3 kg reduction at 2 years with injectable semaglutide in the SUSTAIN-6 trial

Centers for Medicare & Medicaid Services this month launched an 18-month trial program that for the first time opens access to Novo Nordisks Wegovy and Eli Lillys Foundayo and Zepbound as weight-loss treatment alone for a monthly cost of $50

Clinical trial data demonstrating average weight loss of 15-22% of baseline body weight has shifted patient and provider perceptions about what's possible with medication